Did you know that elderly people are at higher risk of having acute bacterial meningitis associated with an earlier and higher mortality rate than in younger patients ?
Discover a clinical case illustrating how rapid multiplex PCR can support patient management and treatment in the context of a patient suffering from COVID-19 in the context of a co-infection with Aspergillus
As part of a CIDRAP three-part webinar series, bioMérieux is proud to support this second installment that explores the shifting landscape of the rapid diagnostic laboratory, highlighting the transformative impact brought about by new technologies.
Did you know that Hospital Acquired Pneumonia is the second most common nosocomial infection and accounts for more than 50% of the antibiotics prescribed?
Did you know that Hospital Acquired Pneumonia is the second most common nosocomial infection and accounts for more than 50% of the antibiotics prescribed?
Results from the Society of Critical Care Medicine Discovery VIRUS international COVID-19 Registry aim to determine the rate and factors associated with early empiric antibiotic (EEAB) treatment to help set goals for antimicrobial stewardship efforts, in the post-pandemic era.
According to predictions from professor and practicing intensivist, Dr. Hannah Wunsch, war, multidrug resistance, climate change, emerging diseases, and reduced confidence in vaccination will be among the factors that influence an expected increase in infectious diseases in the ICU.
Global antimicrobial resistance (AMR) — the “silent pandemic” — is already causing a significant burden on healthcare systems, with COVID-19 only adding to the complexity and challenge of this global public health threat.
In this article, Brian Raux, PharmD, discusses the global impact COVID-19 has had on the rise of antimicrobial resistance (AMR) and the alarming increase of hospital-acquired infections (HAI).
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota interviewed Christian Lillis, founder of the Peggy Lillis Foundation, about the fight against Clostridioides difficile through education, awareness, and reducing unnecessary antibiotic use.
A group of global experts from Italy, Lebanon, Thailand, India, the U.S., Colombia and China speak about the need for rapid diagnostic tests and efficient laboratory workflows for multi-drug resistant (MDR) Gram-negative infections.
Researchers around the world worked together to identify educational gaps and systemic barriers obstructing adherence to antimicrobial stewardship (AMS) principles in France, India, Mexico, and the United States.
bioMérieux pharmacist Tristan Timbrook and team analyzed data from the BIOFIRE® Pneumonia (PN) and BIOFIRE® Blood Culture Identification 2 (BCID2) Panels using BioFire Syndromic Trends, a cloud-based surveillance network software, to determine the prevalence of multi-drug resistant organisms (MDRO) across various US region
In their proof-of-concept study, Dr. Claeys and colleagues compared three rapid diagnostic test panels using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy, or DOOR MAT, to diagnose Gram-negative bloodstream infections.
-Panel?qlt=85&wid=1024&ts=1740761868393&dpr=off)
